(R)-(1,2,3,4-Tetrahydroisoquinolin-3-yl)methanol, 95.0%, 250mg

2-Oxabicyclo[2.1.1]hexan-4-ylmethanol, 98%, 250mg

Matraces de fondo redondo con doble cuello, 50 ml, 14/23, 14/23, 1 Pieza

Benzothiazole-2-yl-acetonitrile, 97.0%, 1g

1-(6-(4-Chlorophenoxy)pyridin-3-yl)ethanone, 95%, 1g

3-Fluoropyridine-2-carboxylic acid, 98.0%, 25g

3,5-Diethynylpyridine>96.0%(GC)5g

4-Bromo-2-nitrobenzoic acid, 97.0%, 10g

2'-chloro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] hydrochloride, 95.0%, 250mg

[(S)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl]ruthenium(II) Dichloride250mg

ETHYL 2-CYCLOPROPYLIDENEPROPANOATE, 95.0%, 1g

2-Benzylpyrazine, 95.0%, 100mg

Columna HPLC NUCLEODUR® 100-3 C18 ec 3 µm, 100 mm, 4 mm, 1 Pieza(s)